PRISM for Cancer
(PRISM-AC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test a program called Promoting Resilience in Stress Management (PRISM) for teens and young adults with advanced cancer. The goal is to determine if PRISM provides better emotional support than usual care. Participants will learn skills to manage stress and build resilience. Those aged 12 to 24 with advanced cancer who can participate in interviews might be suitable for this study. As an unphased trial, this study offers a unique opportunity to contribute to research that could improve emotional support for young cancer patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the PRISM intervention is safe for adolescents and young adults with advanced cancer?
Research has shown that the Promoting Resilience in Stress Management (PRISM) program is safe for teens and young adults with cancer. Studies have found that PRISM includes four coaching sessions that help patients manage stress, set goals, change negative thoughts, and find meaning in their experiences.
These studies have reported no serious side effects. The program focuses on building resilience, helping individuals recover from stress. It is well-tolerated, with no harmful effects linked to it. This suggests that the PRISM program is safe to try and could improve mental well-being during challenging times like cancer treatment.12345Why are researchers excited about this trial?
Researchers are excited about PRISM for cancer patients because it offers a fresh approach to dealing with the psychological stress of the disease. Unlike traditional psychosocial care, which often focuses on providing general emotional support, PRISM emphasizes resilience skills training. This means it actively teaches patients how to manage stress and bounce back from challenges. By building these skills, PRISM aims to improve patients' overall well-being and quality of life during treatment, offering a proactive way to handle the emotional side of cancer.
What evidence suggests that the PRISM intervention is effective for adolescents and young adults with advanced cancer?
Research has shown that the Promoting Resilience in Stress Management (PRISM) program, which participants in this trial may receive, can help teenagers and young adults with advanced cancer. In past studies, PRISM boosted resilience and reduced stress. For example, after three months, participants in PRISM reported feeling more resilient and hopeful than those who did not participate. Another study demonstrated that PRISM improved aspects of patients' overall well-being. These results suggest that PRISM may help young cancer patients manage stress better and enhance their emotional health.36789
Who Is on the Research Team?
Abby R Rosenberg, MD, MS, MA
Principal Investigator
Dana-Farber Cancer Institute
Are You a Good Fit for This Trial?
This trial is for adolescents and young adults aged 12-24 with advanced cancer, who can speak and read English or Spanish. They should be cognitively able to participate in interviews. It's not open to those whose parents refuse participation (if under 18) or if the patient themselves refuses.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention Adaptation
Adapt and iteratively test the existing PRISM intervention based on established guidelines for intervention development
Treatment
Participants receive the PRISM intervention, which includes four 30-60 minute, in-person, one-on-one sessions plus a facilitated family meeting
Follow-up
Participants are monitored for psychosocial well-being and quality of life outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Promoting Resilience in Stress Management (PRISM)
Promoting Resilience in Stress Management (PRISM) is already approved in United States for the following indications:
- Chronic Musculoskeletal Pain in Adolescents
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dana-Farber Cancer Institute
Lead Sponsor
Pittsburgh Children's Hospital
Collaborator
Children's Hospital Los Angeles
Collaborator
National Cancer Institute (NCI)
Collaborator
University of Pittsburgh Medical Center
Collaborator
Seattle Children's Hospital
Collaborator
Baylor College of Medicine
Collaborator